A structured and digitalised approach to investing in a healthier future

Sciety combines efficient processes and advanced tech solutions with deep expertise in life science to identify and support the most promising life science innovations

The Sciety Approach

Sciety is a leading investment company, committed to supporting the growth of innovative life science and health tech companies in the Nordic region. Our philosophy is that impact and financial return should go hand in hand. What guides us in handpicking our portfolio companies is their potential to make an impact in their respective industries. We invest alongside the investor network Sciety Venture Partners and frequently co-invest with leading life science venture capital firms in Europe.

We know the Nordic life science industry

At Sciety, we operate at the heart of the Nordic life science industry. Our expertise and connections span from the ground up, encompassing the companies that lead the charge as well as the pioneering researchers at the top universities. Our insights about the evolving life science field offer a window into future directions and potential benchmarks. 

With a vast network of industry connections as well as advisory relationships with eminent figures such as Mathias Uhlén (initiator of The Human Protein Atlas), Bengt Julander (founder of Linc) and Mats Nilsson (co-founder of Olink), Sciety has a unique position that allows us to bridge the gap between groundbreaking research and significant market players, ensuring our partners are always one step ahead.

Sciety news

“Sciety has a strong deal flow and solid know-how within life science and healthcare. Linc has invested in several unlisted life science companies together with Sciety.”

Bengt Julander, founder of Linc

Advanced tech solutions

At the core of our operations lies what we refer to as our foundational infrastructure — consisting of cutting-edge digital technologies and intelligent systems design, which many industry experts acknowledge as unprecedented. Our foundational infrastructure is built to handle a high volume of data and transactions smoothly and efficiently. Through automation and smart financial solutions, we are able to navigate the industry with unparalleled agility and insight. Our unique position is a clear indicator that size does not define influence. Rather, it is our smart, structured approach to technology and business that makes us a significant player in our field.

Extensive database of companies

Our extensive database of life science companies offers exclusive insights and facilitates connections across the industry. We track and analyse the progression of companies, leveraging advanced systems to maintain a comprehensive overview. With a steady stream of new companies, our operations are efficiently managed, utilising intelligent methods to ensure precision and accuracy in our analysis. But our expertise isn’t just technical; it’s fundamentally anchored in a deep understanding of the life science industry. This thorough and organised approach gives us unique insights into the fluctuations and trends that define the Nordic life science market.

Deep life science expertise

Our team is comprised of scientists, business professionals, 
and entrepreneurs with a deep understanding of the life science and healthcare industries. Our combined experience in business development, management, digital healthcare, scientific research, clinical practice, and investments makes us uniquely qualified to handpick the most promising unlisted life science companies and innovations.

Actively supporting our portfolio companies

At Sciety, we are committed to being more than just an investor; we are active partners dedicated to supporting the growth of the companies we invest in. Our involvement goes beyond financial contributions, extending into hands-on support that helps bridge connections to potential customers and partners, and solidifying interest from major players in the life science industry. We provide a comprehensive support system, offering operational and strategic advice as well as facilitating valuable introductions for our portfolio companies.

What we invest in

Biotechnology

From late preclinical trial phase to phase II clinical trials. All therapeutic areas.

Medical technology

From clinical validation phase to expansion phase.

Pharmacology

From late preclinical phase to Phase II clinical trials. All therapeutic areas.

Diagnostics

From clinical validation to expansion phase. All indications.

ICT in healthcare

From pilot phase to expansion phase. Solutions for healthcare and research.

Health tech

From early sales to expansion phase. Preventive care and healthcare.

Get in touch

Interested in co-investing with us? Please contact Andreas Lindblom, Managing Partner

Sign up for news

Want to receive our latest updates and insights? Sign up and we will keep you posted.

Sign me up please